BIOAFFINITY TECHNOLOGIES INC (BIAF) Stock News
NASDAQ:BIAF - Nasdaq - US09076W1099 - Common Stock - Currency: USD
BIAF Latest News, Press Relases and Analysis
These stocks that are showing activity before the opening bell on Thursday.
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Mentions: ASPI
These 3 Healthcare Stocks Show Serious Muscle Amid Trump Tariff Turmoil: Are Retail Traders Feeling Bullish?
iCoreConnect, BioAffinity and Alaunos Therapeutics posted strong gains last week amid heavy trading volume.
Why Penguin Solutions Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
On Wednesday, there are stocks with unusual volume. Let's take a look.
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Tuesday's after hours session: top gainers and losers
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Curious about the most active stocks on Tuesday?
Stay updated with the latest market activity on Tuesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
These stocks have an unusual volume in today's session
Volume analysis on 2025-04-01: stocks with an unusual volume in today's session.
What's going on in today's after hours session
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024
bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Mentions: CANF
Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer
Case Study: bioAffinity Technologies’ Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence
Physicians’ Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer
bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth
WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that – bioAffinity...
bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million
WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million
/PRNewswire/ -- WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity...
